Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
25 and 50 mg diclofenac K film coated immediate release tablets More
Fentanyl patch for the management of severe pain in patients who require continuous opioid analgesia. More
Range of Glucosamine based pharmaceutical products (capsule,tablets,sachets,) authorized in some countries of Europe or ready to register. More
The First Line of Therapy in Severe Migraine Attacks More
The first pure, immediate release (Tmax in 13,68 min), completely palatable and free from aftertaste diclofenac potassium formulation in drops at 5% available on the market More
Ultrashort acting beta blocker Esmolol for use in anesthesia, intensive care, cardiology and internal medicine. More
The plant milking technology is capable of producing high value active pharmaceutical compounds More
Opioid receptor blocker which reduces desire for opioids and alcohol, use in psychiatry, neurology and addition medicine. More
Kappa opioid receptor agonist/ mü antagonist providing analgesia, while preventing respiratory depression More
Opioid receptor antagonist reducing opioid induced respiratory depression More
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2010 - 37 pages - $5,700
Dec 2010 - 58 pages - $5,700
Mar 2009 - 59 pages - $5,700
Jun 2010 - 48 pages - $5,700
Dec 2010 - 55 pages - $5,700
Jun 2010 - 68 pages - $5,700
Dec 2010 - 57 pages - $5,700
Nov 2010 - 111 pages - $5,700
Dec 2010 - 50 pages - $5,700
Apr 2011 - 58 pages - $3,800
Your selection
Browse By
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us